Pegfilgrastim with VMI
ID: RFP_75A50324R00004Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEASPR/ORM-SNSAtlanta, GA, 30341, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY (3650)
Timeline
    Description

    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of Pegfilgrastim 6MG/.06ML injection solutions and Vendor Managed Inventory (VMI) services under Solicitation No. 75A50324R00004. The primary objective is to ensure the availability of this critical medication, which is essential for treating acute radiation syndrome and supporting public health emergencies, through a five-year contract that includes a base year and four optional ordering periods. Interested contractors must adhere to strict compliance with FDA regulations, manage inventory effectively, and ensure rapid deployment capabilities during emergencies. Proposals are due by October 2, 2024, and inquiries can be directed to LaMonica Norwood at OSContracting@hhs.gov.

    Point(s) of Contact
    LaMonica Norwood
    OSContracting@hhs.gov
    Files
    Title
    Posted
    The Technical - Past Performance Questionnaire is a component of a federal RFP requiring Offerors to submit past performance data for up to three contracts completed within the last three years. These contracts must be relevant in terms of scope, magnitude, and complexity in relation to the current RFP. For each contract, Offerors must provide basic information such as the contract number, agency name, and title, along with a narrative describing the work performed, relevant outcomes, challenges encountered, and corrective actions taken. Additionally, Offerors must disclose the contract's dollar value, type, performance period, and delivered products. A point of contact (POC) for each project must be provided to facilitate potential follow-up by the government for further clarification or evaluation. This request emphasizes the importance of past experience in securing new contracts, ensuring that Offerors demonstrate their capacity to fulfill the requirements set forth in the RFP based on previous successful engagements.
    The HHS Industry User Guide for Subcontracting Plan Reviews outlines the procedures for vendors to submit subcontracting plans for evaluation by the Department of Health and Human Services (HHS). Vendors can access their plans through the SBCX account portal, where they will find sections for project summaries, subcontracting goals, document uploads, and communication with contracting officials. To complete a subcontracting plan, vendors must identify the plan type, report eligible subcontracting dollars, provide necessary goal data, and specify the Subcontracting Program Administrator. Additionally, they are required to describe inclusion efforts for small businesses and certify the plan's completion and compliance. After submission, a PDF version of the plan is available, and contracting officers may request revisions if needed. The evaluation process involves three approvers—Contracting Officer, Small Business Specialist, and SBA Procurement Center Representative. Support for technical issues is offered via email. This guide is essential for ensuring that vendors meet subcontracting goals while adhering to federal regulations in the context of RFPs and grants.
    This government request for proposal (RFP) outlines the U.S. Department of Health and Human Services' need for Pegfilgrastim 6MG/.06ML (inj, soln, syr, or autoinjector) and vendor-managed inventory (VMI) services, designed to support national preparedness against public health emergencies. The procurement will take place over a five-year period, including a one-year base period and four optional ordering periods. The contract anticipates a combination of firm-fixed price and time-and-material services, with a projected initial quantity of 18,300 units, increasing in subsequent years based on public health needs. The contractor must ensure compliance with FDA regulations and maintain a secure, temperature-controlled environment for inventory. The contractor is tasked with managing inventory effectively through VMI practices, ensuring sufficient stock levels and quality control within defined timelines. Shipping and transportation services for the products must align with stringent federal guidelines, emphasizing the importance of rapid deployment potential in emergencies. Overall, this solicitation underscores the federal government's commitment to maintaining robust health security capabilities and optimizing supply chain efficiency for essential pharmaceuticals.
    Amendment 1 to RFP 75A50324R00004 serves to update the proposal submission guidelines for contractors in relation to pharmaceutical supplies under the ASPR/SNS program. Key changes include an extension of the proposal submission deadline, now due by October 2, 2024, at 4:00 PM Eastern Time. The amendment also addresses questions and answers relevant to the RFP and provides a link for offerors to submit subcontracting plans. Additionally, it incorporates the FAR Clause 52.232-18 regarding the availability of funds for all Contract Line Item Numbers (CLINs) specified in the solicitation. The document outlines important codes, solicitation numbers, and identifies HHS as the administering entity, emphasizing adherence to Federal Acquisition Regulation (FAR) standards and procedures for offerors. Overall, the amendment ensures clarity in the procurement process and compliance with federal guidelines, facilitating a smoother submission and evaluation process for potential contractors.
    The document outlines a Request for Proposal (RFP) #75A50324R00004 from the Department of Health and Human Services (HHS) for the procurement of Pegfilgrastim 6MG/.06ML injection solutions and Vendor Managed Inventory (VMI) services. The RFP emphasizes a full and open competitive process and is not set aside for small businesses. It details that the HHS aims to secure this medication essential for treating acute radiation syndrome and supporting public health emergencies. Key components include an itemized breakdown of costs over a five-year period, including a base year and four optional ordering periods. The contractor is responsible for inventory management, quality control, transportation services, and ensuring compliance with cGMP and applicable FDA regulations. The scope requires maintaining optimal inventory levels, efficient storage, and disaster readiness with a focus on rapid deployment during emergencies. The contractor must adhere to strict protocols for shipping, labeling, and documenting inventory to guarantee timely access to the pharmaceuticals. Overall, this RFP highlights the government's proactive approach to public health preparedness by ensuring the availability of critical treatment options and enhancing logistical capabilities through VMI services.
    The document outlines the Offeror Representations and Certifications for Commercial Products and Services, specifically focusing on the necessary certifications and compliance related to federal contracting. It requires Offerors to either confirm their annual certifications in the System for Award Management (SAM) or provide detailed representations concerning their business status, such as small business and veteran-owned classifications. Key definitions include small disadvantaged businesses, economically disadvantaged women-owned small businesses, and service-disabled veteran-owned small businesses, among others. The provision mandates disclosures regarding business operations, particularly concerning controversial areas like child labor, restricted operations in Sudan, and non-compliance with telecommunications regulations. It also includes stipulations about the "Buy American" requirements and certifications related to federal tax compliance and criminal convictions. The primary purpose of this document is to establish a baseline of representations and certifications necessary for Offerors participating in federal contracts, ensuring transparency and compliance with federal regulations, while also promoting socioeconomic goals within government procurement processes. It serves as a framework to verify the eligibility of contractors based on various criteria pertinent to federal funding, ensuring that the government contracts with responsible and qualified entities.
    The document pertains to a Request for Proposal (RFP) for acquiring Pegfilgrastim 6MG/.06ML (injection solution, syringe, or autoinjector) alongside Vendor Managed Inventory (VMI) services, identified as Solicitation No. 75A50324R00004. It includes a Q&A format addressing various contractor inquiries. The government intends to exercise option years unilaterally as specified in the solicitation. An extension for proposal submission has been granted until October 2, 2024. Questions raised include the possibility of extending the proposal deadline, checking the Strategic National Stockpile (SNS) coverage, and the evaluation criteria for domestic supply chains or ease of use in autoinjector forms. The government clarifies that all proposals will be reviewed without prioritizing domestic supply chains or autoinjector ease of use in evaluation criteria. Multiple pricing submissions for different Pegfilgrastim forms are allowed. The document's structure facilitates clear communication of responses to contractors while detailing expectations for proposal submissions in line with federal regulations and requirements.
    This document serves as a Solicitation Q&A Sheet for a government Request for Proposals (RFP). It is designed for contractors to submit questions concerning the RFP, with a structured format to capture pertinent details such as the section, page, and specific questions raised by the vendors. Each contractor's inquiry is followed by a government response that is highlighted in blue for clarity. The file contains multiple sections where questions and responses can be filled in, indicating ongoing interactions between the government and vendors regarding the RFP process. The purpose of this document is to ensure transparency and facilitate clear communication between the government and potential contractors, thereby enhancing the overall efficiency and effectiveness of the procurement process. By consolidating all questions and providing unified responses, the government aims to create an equitable environment for all vendors involved. Overall, this Q&A Sheet plays a crucial role in ensuring that all parties have a clear understanding of the RFP stipulations and expectations.
    The document serves as a Solicitation Q&A Sheet related to RFP No. 75A50324R00004, outlining contractor inquiries and government responses concerning inventory management for a government contract. Key topics include inventory system access, production capacity requirements, deployment timelines for drug products in emergencies, and shelf-life criteria for deliveries. The government clarifies that contractors need not provide immediate complete inventory but must develop a detailed delivery schedule and production ramp-up strategy. Additionally, there is a twelve-hour notification for emergency shipment delivery, requiring contractors to maintain sufficient stock levels in compliance with regulations. The requirement for 90% shelf-life of products upon government procurement is also emphasized. Contractors must acknowledge amendments to the RFP and provide appropriate delivery timelines in case of increased quantities. Overall, the document highlights essential operational expectations for contractors to ensure effective supply management in public health emergencies.
    This document outlines a pricing template for the procurement of Pegfilgrastim and related services through a federal government solicitation. The contract spans a base year from September 30, 2024, to September 29, 2025, with options for additional quantities and services extending through September 2029. Key components include the delivery of Pegfilgrastim injection solutions, vendor-managed inventory (VMI) services, and transportation services, all categorized under various Contract Line Item Numbers (CLINs). Each CLIN specifies quantity, pricing structure (firm fixed price or time and materials), and references a Statement of Work (SOW). The document delineates base quantities starting with 18,300 units, with potential increases in subsequent optional periods, reaching up to 60,300 units. The purpose of the RFP is to secure essential pharmaceutical supplies and services, illustrating the federal commitment to managing healthcare resources efficiently. This structured approach ensures clear financial expectations while adhering to procurement standards necessary for government contracts.
    Lifecycle
    Title
    Type
    Pegfilgrastim with VMI
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services to support the development of drug products. The objective of this procurement is to ensure the delivery of high-quality formulated drug products for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic development. This opportunity encompasses a wide range of services, including formulation development, manufacturing under current Good Manufacturing Practices (cGMP), and necessary testing to meet regulatory standards. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can contact Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    Public Health Industrial Base Capabilities and Capacities: Anti-Microbials
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking industry partners to provide information on domestic production capabilities related to anti-microbials as part of the Defense Production Act Title III Program. The objective is to gather data that will enhance the understanding of the Public Health Industrial Base (PHIB) and identify gaps in the marketplace that can be addressed through Title III authorities, which incentivize domestic production. This initiative is crucial for ensuring a reliable supply of essential health resources necessary for national defense and public health, particularly in light of the recent Presidential Determination 2024-03. Interested parties are invited to submit their responses by January 22, 2025, at 10 AM ET, to Chris Newell at IBMSC-Submissions@hhs.gov or Christopher.Newell@hhs.gov.
    6505--ILLUCCIX PSMA VASD
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA), through the Network Contracting Office (NCO) 22, intends to award a sole source firm-fixed price contract to Cardinal Health 414, LLC for the procurement of Illuccix PSMA radioactive therapy injections. This procurement is justified under FAR 8.405-6(a)(1)(B), as only one source can provide the unique supplies necessary for treating prostate cancer patients undergoing Positron Emission Tomography (PET) imaging. The Illuccix PSMA injection is FDA approved for patients with prostate cancer, particularly for those whose cancer may have metastasized or recurred, making it a critical component in their treatment. Interested parties must submit a tailored capability statement and relevant company information by 10:00 AM PT on January 21, 2025, to Hestia.Sim@va.gov, as the VA reserves the right to proceed with Cardinal Health if no adequate responses are received.
    A--National Gene Vector Biorepository
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) contract, aimed at supporting gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract will involve archiving biological specimens, conducting DNA and RNA extractions, and developing assays, while ensuring compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is critical for advancing gene therapy capabilities and enhancing research resources, with an expected proposal submission deadline of January 10, 2025, and a revised due date for proposals set at 2:00 PM EST on January 15, 2025. Interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153 for further information.
    CONSUMABLES FOR HYDROPAC WATERING SYSTEM
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for consumables for the Hydropac watering system, as outlined in solicitation number RFQ-NIAID-25-2254249. The primary requirement includes a Hydropac Master Carton containing 72,000 valves and 36 rolls of pouch film, which are essential for the operational effectiveness of the NIH in managing infectious diseases. This procurement is structured under the Federal Acquisition Regulation (FAR) Subpart 12.6 for commercial items, emphasizing a brand name restriction to ensure compatibility with existing systems. Interested vendors must submit their offers by January 22, 2025, to Calvin Robinson at calvin.robinson@nih.gov, and must be registered in the System for Award Management (SAM) prior to award.
    Hardy Diagnostic Reagents and Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Metformin SA Tablets through its Repack Program, aimed at ensuring a stable supply of essential pharmaceuticals for veteran healthcare. Bidders are required to adhere to strict FDA good manufacturing practices, propose pricing that includes a 0.5% Cost Recovery Fee, and comply with the Drug Supply Chain Security Act regulations, among other requirements. This procurement is critical for maintaining the availability and quality of medications for veterans, reflecting the government's commitment to their healthcare needs. Interested contractors must submit their offers by January 21, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    Pre-Solicitation Notice - Clinical East Staffing IDIQ
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is preparing to solicit proposals for the Clinical East Staffing Indefinite Delivery/Indefinite Quantity (IDIQ) contract, aimed at securing occupational health services for the Federal Occupational Health (FOH) program. This contract will provide essential staffing services to enhance health outcomes and employee productivity while minimizing occupational health risks and healthcare costs for federal agencies. The anticipated solicitation is set to be released in the second quarter of Fiscal Year 2025, with the contract duration not exceeding five years. Interested parties can direct inquiries to Angelina Mulenga at angelina.mulenga@psc.hhs.gov or Saundra Kpadeh at saundra.kpadeh@hhs.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and biodosimetry devices. The primary objectives are to create MCMs that mitigate normal tissue injuries from ionizing radiation and to advance biodosimetry methods to enhance triage and treatment during radiation emergencies, with each proposal focusing on one of these goals. This initiative is crucial for national preparedness against potential radiological incidents, as it aims to improve the response to radiation exposure and associated health risks. Proposals are due by March 19, 2025, and interested parties must register in the System for Award Management (SAM); the estimated cost and fixed fee for the contract are to be determined. For further inquiries, contact Albert Nguyen at nguyenal@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.